Chase Knickerbocker
Stock Analyst at Craig-Hallum
(3.25)
# 274
Out of 4,827 analysts
36
Total ratings
47.22%
Success rate
2.73%
Average return
Main Sectors:
Stocks Rated by Chase Knickerbocker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETON Eton Pharmaceuticals | Maintains: Buy | $23 → $26 | $17.33 | +50.03% | 5 | Mar 19, 2025 | |
| XERS Xeris Biopharma Holdings | Maintains: Buy | $5 → $6.5 | $5.16 | +25.97% | 1 | Mar 7, 2025 | |
| MDWD MediWound | Initiates: Buy | $39 | $17.46 | +123.37% | 1 | Feb 28, 2025 | |
| IRWD Ironwood Pharmaceuticals | Maintains: Buy | $10 → $8 | $0.70 | +1,043.02% | 4 | Jan 22, 2025 | |
| DCTH Delcath Systems | Maintains: Buy | $18 → $21 | $14.36 | +46.29% | 2 | Jan 17, 2025 | |
| KRMD KORU Medical Systems | Maintains: Buy | $5 → $6 | $3.29 | +82.37% | 2 | Jan 17, 2025 | |
| SCPH scPharmaceuticals | Maintains: Buy | $16 → $12 | $2.51 | +378.09% | 2 | Nov 14, 2024 | |
| PYPD PolyPid | Initiates: Buy | $10 | $2.77 | +261.01% | 1 | Nov 4, 2024 | |
| INDV Indivior | Maintains: Buy | $20 → $16 | $10.98 | +45.72% | 3 | Oct 11, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $65 | $23.59 | +175.54% | 3 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $15 | $6.21 | +141.74% | 4 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $7.42 | +61.73% | 2 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $8.08 | +23.76% | 1 | Jul 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $23 | $9.39 | +144.94% | 2 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1 → $1.2 | $0.53 | +128.01% | 2 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $21 | $2.29 | +817.03% | 1 | Mar 13, 2023 |
Eton Pharmaceuticals
Mar 19, 2025
Maintains: Buy
Price Target: $23 → $26
Current: $17.33
Upside: +50.03%
Xeris Biopharma Holdings
Mar 7, 2025
Maintains: Buy
Price Target: $5 → $6.5
Current: $5.16
Upside: +25.97%
MediWound
Feb 28, 2025
Initiates: Buy
Price Target: $39
Current: $17.46
Upside: +123.37%
Ironwood Pharmaceuticals
Jan 22, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $0.70
Upside: +1,043.02%
Delcath Systems
Jan 17, 2025
Maintains: Buy
Price Target: $18 → $21
Current: $14.36
Upside: +46.29%
KORU Medical Systems
Jan 17, 2025
Maintains: Buy
Price Target: $5 → $6
Current: $3.29
Upside: +82.37%
scPharmaceuticals
Nov 14, 2024
Maintains: Buy
Price Target: $16 → $12
Current: $2.51
Upside: +378.09%
PolyPid
Nov 4, 2024
Initiates: Buy
Price Target: $10
Current: $2.77
Upside: +261.01%
Indivior
Oct 11, 2024
Maintains: Buy
Price Target: $20 → $16
Current: $10.98
Upside: +45.72%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $65
Current: $23.59
Upside: +175.54%
Aug 14, 2024
Maintains: Buy
Price Target: $17 → $15
Current: $6.21
Upside: +141.74%
Aug 1, 2024
Maintains: Buy
Price Target: $14 → $12
Current: $7.42
Upside: +61.73%
Jul 11, 2024
Initiates: Buy
Price Target: $10
Current: $8.08
Upside: +23.76%
May 9, 2024
Maintains: Buy
Price Target: $22 → $23
Current: $9.39
Upside: +144.94%
Jul 11, 2023
Maintains: Buy
Price Target: $1 → $1.2
Current: $0.53
Upside: +128.01%
Mar 13, 2023
Initiates: Buy
Price Target: $21
Current: $2.29
Upside: +817.03%